Asian markets extend rally as China data lifts optimism

Published 01-APR-2019 15:03 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Asian markets rallied Monday, building on last week's healthy gains with investors buoyed by optimism over China-US trade talks and forecast-busting Chinese factory data.

Top negotiators from China and the US flagged progress in last week's discussions in Beijing on the tariffs row, with another round slated for this week in Washington.

While there have been few details, the general view on trading floors is that the economic superpowers are heading towards a deal that will end a long-running spat that helped sink global markets towards the end of last year.

Confidence an agreement will be reached helped overcome concerns about the world economy that saw a sharp sell-off in equities at the start of last week.

A positive lead from Wall Street was picked up in Asia, with Tokyo ending the morning 2.2 percent higher, Hong Kong adding 1.6 percent and Shanghai climbing 2.3 percent.

Sydney and Singapore each jumped 0.8 percent, while Seoul piled on 1.2 percent, with Taipei and Wellington also in the green.

The rises were supported by a sharp jump in an index of Chinese manufacturing activity, which soothed concerns about the world's number two economy and a key driver of the global economy.

- EU patience 'running out' -

The Purchasing Managers Index for March showed growth in the sector for the first time in four months and was far better than expected.

"The manufacturing print... will go a long way to allaying slowdown fears about China, at least in the short-term as the US-China trade talks move back to Washington this Wednesday," said OANDA senior market analyst Jeffrey Halley.

Attention once again returns to Britain, where Prime Minister Theresa May failed on Friday to pass her Brexit deal through parliament, stoking uncertainty with just over a week before the deadline for leaving the European Union.

With MPs still unable to agree on a way forward there are fears the country will crash out of the bloc without a deal, putting pressure on the pound.

Lawmakers will hold a series of votes Monday to try to find a majority-backed plan to end the current crisis, though European Commission President Jean-Claude Juncker has said the EU is "running out" of patience as the saga plods on.

"Brexit is a mess, and sterling traders are getting bored with the continued political point scoring that has plagued the whole process," said James Hughes, chief market analyst at AxiTrader.

"The closer we get to the proposed deadline of April 12 the more volatility we will surely see."

- Key figures around 0230 GMT -

Tokyo - Nikkei 225: UP 2.2 percent at 21,679.44 (break)

Hong Kong - Hang Seng: UP 1.6 percent at 29,527.14

Shanghai - Composite: UP 2.3 percent at 3,161.01

Pound/dollar: UP at $1.3027 from $1.3023 at 2100 GMT on Friday

Euro/pound: UP at 86.19 pence from 86.14 pence

Euro/dollar: UP at $1.1227 from $1.1217

Dollar/yen: UP at 111.09 yen from 110.82 yen

Oil - West Texas Intermediate: UP 31 cents at $59.45 per barrel

Oil - Brent Crude: UP 40 cents at $67.98 per barrel (new contract)

New York - Dow: UP 0.8 percent at 25,928.68 (close)

London - FTSE 100: UP 0.6 percent at 7,279.19 (close)

dan/hg

© Agence France-Presse



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X